Related Experiment Video
Updated: May 14, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Lenalidomide in lymphomas and chronic lymphocytic leukemia
1Continuum Cancer Centers of New York, St. Lukes-Roosevelt and Beth Israel Medical Center, Leukemia Program, 1000 10th Ave, Ste. 11C-02, New York, NY 10019, USA. pwiernik@aol.com
Expert Opinion on Pharmacotherapy
|January 30, 2013
Summary
Lenalidomide, a novel antineoplastic drug, shows significant efficacy in hematologic malignancies. This review highlights its mechanisms and clinical results in lymphoma and chronic lymphocytic leukemia management.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Lenalidomide is a thalidomide analog with anti-inflammatory, anti-angiogenic, and immunomodulatory properties.
- It demonstrates efficacy in hematologic malignancies like myeloma and myelodysplasia.
- Lenalidomide offers antitumor activity comparable or superior to thalidomide with reduced toxicity.
Purpose of the Study:
- To summarize the mechanisms of action of lenalidomide.
- To review recent clinical results of lenalidomide in lymphoma and chronic lymphocytic leukemia.
Main Methods:
- Literature review of PubMed publications from 2000-2012.
- Searched using terms: lenalidomide, lymphoma, chronic lymphocytic leukemia, Hodgkin's lymphoma.
- Manual search of conference proceedings and relevant references.
Main Results:
- Lenalidomide exhibits direct cytotoxicity and interferes with the tumor microenvironment.
- Clinical data on lenalidomide in lymphoma and chronic lymphocytic leukemia were analyzed.
- The drug's efficacy and safety profile were evaluated based on existing literature.
Conclusions:
- Lenalidomide is a promising therapeutic agent for lymphoid neoplasms.
- It is expected to play a significant role in managing B-cell lymphoma and chronic lymphocytic leukemia.
- Potential applications may extend to T-cell lymphoma treatment.
Related Concept Videos
01:18Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...